Published date: 15 August 2023
Last edited date: 15 August 2023
Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
WA7 2ES
Value of contract
£55,000,000
Procurement reference
CF-1794100D0O000000rwimUAA
Published date
15 August 2023
Approach to market date
1 October 2023
Contract start date
1 January 2024
Contract end date
31 December 2025
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
CM/PHR/23/5701 NHS National Proprietary Pharmaceuticals - Natalizumab Injection
More information
Previous notice about this procurement
CM/PHR/23/5701 NHS National Proprietary Pharmaceuticals - Natalizumab Injection
- Future opportunity
- Published 15 August 2023
About the buyer
Contact name
Katie Noonan
Address
Rutland House
Runcorn
WA7 2ES
UK
Share this notice
Approach to market date: 1 October 2023
All content is available under the
